BIOGEN

DC

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 7 of its records are shown together here.

Filings
208
Filed By
7
Reported In-House
$51,331,680
Reported By Firms
$5,190,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2023 BIOGEN 2nd Quarter (Apr 1 - June 30)
AMENDED
$830,000
2023 THORN RUN PARTNERS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination
$50,000
2023 BIOGEN 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$940,000
2023 THORN RUN PARTNERS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2023 BIOGEN 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$1,090,000
2023 BIOGEN 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$790,000
2023 THORN RUN PARTNERS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$50,000
2023 BIOGEN 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$990,000
2023 THORN RUN PARTNERS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$50,000
2023 CLYBURN CONSULTING, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Termination
$30,000
Filed By
FirmFilingsAmount
BIOGEN IN-HOUSE 81 $51,331,680
W STRATEGIES, LLC 35 $1,700,000
NVG, LLC 44 $1,600,000
THORN RUN PARTNERS 23 $940,000
CAPITOL HILL STRATEGIES, LLC 18 $750,000
CLYBURN CONSULTING, LLC 6 $200,000
LATHAM & WATKINS LLP 1 —
Issue Areas

Bills Mentioned in Filings